Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
10.47 USD
845.04 M USD
3.66 B USD
81.01 M
About IDEXX Laboratories, Inc.
Sector
Industry
CEO
Jonathan J. Mazelsky
Website
Headquarters
Westbrook
Founded
1983
FIGI
BBG000BLRT07
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Resistance Analysis in Bottoming Stocks: IDXX, OKTAResistance Analysis in Bottoming Stocks: Looking Ahead to Q1 2023 Earnings
Stocks that are slowly crawling their way out of the correction of 2022 are now moving up to challenge the more difficult resistance levels from the intermediate-term downtrend. These resistance levels are sideways trends
$IDXX with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for $IDXX after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 42.68%.
IDXX$IDXX - weekly vs. monthly
Weekly (left) - new swing high + MACD crossing above zero line + RSI rising & above 50
Monthly (right) – bullish candle developing off the month 50-day EMA. RSI double bottomed at RSI 38.2 level plus crossed above 50; MACD looks to be crossing after being in a decline si
IDXX - broke out of consolidationIDXX had a strong move last Friday on high volume that brought it to the top of it's 2 months consolidation range high of 447.80. The following Monday (9 Jan),it formed a little Doji Candle just slightly above this level , perhaps traders were still skeptical if this break was for real. The day aft
$IDXX with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $IDXX after a Positive over reaction following its earnings release placing the stock in drift B with an expected accuracy of 75%.
$IDXX with a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $IDXX after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 66.67%.
Ugly TopPrice is below the neckline.
Short is 2.18%.
Possible W pattern forming.
This could go up a bit before going down again.
No recommendation.
Earnings 8-3 BMO
IDXX - Megaphone ContinuationAn idea for IDXX supporting the continuation of a strong trend line in solid white
If this trend line does not hodl then the level in green is a good potential spot for price recovery
Daily timeframe
$IDXX with a Neutral outlook following its earnings #Stocks The PEAD projected a Neutral outlook for $IDXX after a Negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 60%.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IDXX is 423.42 USD — it has increased by 1.79% in the past 24 hours. Watch IDEXX Laboratories, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange IDEXX Laboratories, Inc. stocks are traded under the ticker IDXX.
IDXX stock has fallen by −4.94% compared to the previous week, the month change is a −10.76% fall, over the last year IDEXX Laboratories, Inc. has showed a −0.08% decrease.
We've gathered analysts' opinions on IDEXX Laboratories, Inc. future price: according to them, IDXX price has a max estimate of 566.00 USD and a min estimate of 435.00 USD. Watch IDXX chart and read a more detailed IDEXX Laboratories, Inc. stock forecast: see what analysts think of IDEXX Laboratories, Inc. and suggest that you do with its stocks.
IDXX reached its all-time high on Jul 29, 2021 with the price of 706.95 USD, and its all-time low was 0.84 USD and was reached on Aug 19, 1991. View more price dynamics on IDXX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
IDXX stock is 4.88% volatile and has beta coefficient of 1.37. Track IDEXX Laboratories, Inc. stock price on the chart and check out the list of the most volatile stocks — is IDEXX Laboratories, Inc. there?
Today IDEXX Laboratories, Inc. has the market capitalization of 34.67 B, it has decreased by −9.86% over the last week.
Yes, you can track IDEXX Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
IDEXX Laboratories, Inc. is going to release the next earnings report on Feb 10, 2025. Keep track of upcoming events with our Earnings Calendar.
IDXX earnings for the last quarter are 2.80 USD per share, whereas the estimation was 2.68 USD resulting in a 4.46% surprise. The estimated earnings for the next quarter are 2.40 USD per share. See more details about IDEXX Laboratories, Inc. earnings.
IDEXX Laboratories, Inc. revenue for the last quarter amounts to 975.54 M USD, despite the estimated figure of 980.32 M USD. In the next quarter, revenue is expected to reach 933.38 M USD.
IDXX net income for the last quarter is 232.84 M USD, while the quarter before that showed 203.30 M USD of net income which accounts for 14.53% change. Track more IDEXX Laboratories, Inc. financial stats to get the full picture.
No, IDXX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 7, 2024, the company has 11.00 K employees. See our rating of the largest employees — is IDEXX Laboratories, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IDEXX Laboratories, Inc. EBITDA is 1.24 B USD, and current EBITDA margin is 32.98%. See more stats in IDEXX Laboratories, Inc. financial statements.
Like other stocks, IDXX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IDEXX Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IDEXX Laboratories, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IDEXX Laboratories, Inc. stock shows the sell signal. See more of IDEXX Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.